Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$16 Mln
Revenue (TTM)
$6 Mln
Net Profit (TTM)
$0 Mln
ROE
-3 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
1.7
Industry P/E
--
EV/EBITDA
-0.2
Div. Yield
0 %
Debt to Equity
0.2
Book Value
$3.6
EPS
$-7.5
Face value
--
Shares outstanding
4,498,675
CFO
$-16.86 Mln
EBITDA
$-24.93 Mln
Net Profit
$-32.99 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
bioAffinity Technologies Inc (BIAF)
| 232.2 | 269.8 | 232.2 | -88.0 | -59.0 | -- | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
bioAffinity Technologies Inc (BIAF)
| -95.7 | -37.9 | -8.1 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
bioAffinity Technologies Inc (BIAF)
|
3.9 | 15.9 | 6.2 | -14.9 | -240.8 | -301.8 | -- | 1.7 |
| 7.9 | 5,388.2 | 6,552.2 | -530.2 | -4.1 | -9.2 | -- | 0.9 | |
| 278.3 | 7,510.1 | 2,583.2 | 759.9 | 25.2 | 10.8 | 10 | 1.0 | |
| 36.8 | 5,222.6 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.1 | |
| 112.8 | 6,549.6 | 507.4 | -187.7 | -36.2 | -26.4 | -- | 10.0 | |
| 76.1 | 4,758.4 | 1,541.6 | 233.6 | 21.6 | 21.4 | 21.4 | 4.5 | |
| 178.6 | 9,411.8 | 1,526.9 | -151.5 | 20.0 | -17.1 | -- | 12.9 | |
| 330.4 | 12,964.3 | 1,403.7 | 177.7 | 14.7 | 13.8 | 72.9 | 9.0 | |
| 117.8 | 6,280.4 | 738.3 | 48.9 | 11.4 | 2.4 | 129.6 | 3.0 | |
| 32.1 | 13,716.9 | 6,178.4 | 626.5 | 13.0 | 11.9 | 22.5 | 2.6 |
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates... through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas. Address: 3300 Nacogdoches Road, San Antonio, TX, United States, 78217 Read more
Founder & Executive Chairman of the Board
Mr. Steven Girgenti
Founder & Executive Chairman of the Board
Mr. Steven Girgenti
Headquarters
San Antonio, TX
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of bioAffinity Technologies Inc (BIAF) is $3.92 (NASDAQ) as of 02-Apr-2026 20:00 EDT. bioAffinity Technologies Inc (BIAF) has given a return of -58.96% in the last 3 years.
Since, TTM earnings of bioAffinity Technologies Inc (BIAF) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-0.16
|
0.32
|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
The 52-week high and low of bioAffinity Technologies Inc (BIAF) are Rs 32.10 and Rs 0.69 as of 05-Apr-2026.
bioAffinity Technologies Inc (BIAF) has a market capitalisation of $ 16 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in bioAffinity Technologies Inc (BIAF), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-0.06
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.